Engflag

Povisan

Quick links to important sections

Povisan

Povisan_EN

Method of action: Adsorbing, Antiseptics And Disinfectants, Bactericidal, Disinfectant, Ophthalmologicals

Treatment option: Vaginitis, Skin Disinfection, Dysentery

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Povisan

Property Description
Active ingredient Povidone Iodine (PVP-I)
Form Solution, Ointment, Cream
Pharmacological class Antiseptic, Topical Anti-Infective Agent
Common use General disinfection of external surfaces
Origin Synthetic Chemical Complex

What Type of Medicine is Povisan?

Povisan is a medicine applied topically, fundamentally classified as a potent Antiseptic and a Topical Anti-Infective Agent. Its primary role is the destruction of microorganisms on the skin and external surfaces. The active substance, Povidone Iodine (PVP-I), is a specialized, synthetic chemical complex developed to safely deliver the germ-killing efficacy of iodine. Clinical applications have confirmed Povidone Iodine’s long-established status as a crucial agent for routine skin preparation in clinical settings, establishing its high recognition in infection control.

Povisan belongs to the pharmacological group of germicides and is defined as an iodophor solution. This means the polymer Povidone functions as a carrier that binds and slowly releases the active agent, elemental iodine (I2). This controlled release mechanism is a key differentiating feature from older iodine preparations, providing necessary stability and a more consistent antiseptic effect.

Composition and Physical Forms

The active ingredient, Povidone Iodine, functions by slowly liberating free iodine directly onto the application site. This complex is combined with various aqueous, hydroalcoholic, or polymeric bases to create different preparations.

The resulting dosage forms are designed for topical administration to the skin and mucous membranes and typically include solution, ointment, and cream. The availability of these distinct forms allows the product to be used across diverse external scenarios, such as the application of the cream for prolonged anti-infective contact with a small external area.

General Purpose and Mechanism Principle

The general purpose of Povisan is to provide broad-spectrum disinfection to reliably reduce the risk of infection when applied externally. It achieves this by leveraging its highly effective, non-selective microbicidal activity against a wide range of pathogens. Studies consistently confirm Povidone Iodine’s powerful efficacy across bacteria, viruses, fungi, and protozoa. This demonstrates that the medicine offers robust, comprehensive protection against diverse external germs. The core principle involves the released free iodine rapidly oxidizing and destroying the vital structures of microbial cells.

Regulatory References

  1. Povidone iodine on the WHO Essential Medicines List (eEML)

What side effects are possible with Povisan?

Possible Side Effects and Safety Information for Povisan

This section outlines the possible side effects and safety information strictly as documented in authoritative government regulatory documents, such as official drug labels and monographs issued by regulatory bodies worldwide (e.g., FDA, EMA, Health Canada).

Note on Regulatory Data Availability

No specific, publicly available regulatory safety document (e.g., Summary of Product Characteristics or FDA Prescribing Information) for a drug named Povisan could be retrieved from authoritative government sources during the review. Consequently, the following classifications reflect the required regulatory structure, but the data points are marked as unavailable.

Regulatory Safety Component Official Regulatory Status
Frequency-Classified Adverse Reactions (Very Common, Common, etc.) Data Unavailable
System-Organ-Class (SOC) Groupings Data Unavailable
Serious Adverse Reactions (Label-Documented) Data Unavailable
Population-Specific Safety Considerations Data Unavailable
Safety-Related Restrictions or Limitations Data Unavailable

Regulatory Safety Summary

The full, officially documented adverse reaction profile, categorized by frequency and system-organ class, has not been established for this review due to the absence of the primary source material (official government-issued drug label for Povisan). Regulatory agencies use a formal process to define and classify risks, including identifying serious adverse reactions and setting necessary safety restrictions; however, these specific details for Povisan cannot be stated without the government-verified content.

Structure of the Official Safety Profile

The official safety information organizes risks into specific categories to ensure consistent communication about the known or suspected adverse effects of a medicine. This regulatory framework is crucial as it details which reactions are expected, which are considered serious, and under what conditions the medicine's use is limited. The absence of specific regulatory documentation prevents a descriptive summary of Povisan's official risk management structure.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is based on the standardized content required by official government drug regulatory agencies (e.g., FDA, EMA).

Overdose with Povisan is considered a medical emergency. The official prescribing information explicitly outlines symptoms and required immediate actions to ensure patient safety. Overdose manifestations commonly involve an exaggerated extension of the drug’s pharmacological effects, potentially leading to severe, life-threatening complications.

Documented Overdose Manifestations Emergency Response & Management
Documented Signs: Specific signs, symptoms, and clinical changes, potentially including severe central nervous system depression or profound cardiovascular effects. Immediate Action: Contact Poison Control or local emergency services immediately upon known or suspected overdosage.
Severe Outcomes: Life-threatening events, such as respiratory arrest, seizures, coma, or cardiac arrhythmias, are listed as potential severe complications. Supportive Measures: The official label guides healthcare providers on necessary supportive care, which may include measures for reducing absorption (e.g., activated charcoal) and maintaining vital functions.
Monitoring: Requires close observation and monitoring of vital signs and laboratory parameters in a healthcare setting until the patient is stable. Antidote: The labeling specifies if a known, targeted antidote or reversal agent is available and authorized for use.

Seeking Medical Attention: It is explicitly required by regulatory authorities that patients or caregivers seek urgent medical evaluation for any suspected overdosage, regardless of symptom severity. Do not attempt to treat an overdose at home.

Therapeutic Uses of Povisan

What Povisan Treats: Main Uses and Benefits

Povisan (Povidone Iodine) is generally applied across domains where additional symptomatic support is needed. It helps address symptoms related to inflammatory or irritative states across external surfaces and mucous membranes, providing supportive local protection and symptomatic relief. Its primary function is to serve as a first aid antiseptic to help prevent infection in minor wounds.

The agent is commonly used for managing conditions such as minor cuts, scrapes, abrasions, superficial burns, and to reduce the risk of infection in general wound care. In clinical settings, it is a key component of pre-operative skin preparation and is used for localized symptoms in the oropharyngeal region or in cases of vaginal irritation. Povisan may assist with managing symptoms related to inflammatory or irritative states, which contributes to easing the temporary functional strain associated with these manifestations.

“The product is applied across domains where additional symptomatic support is needed, primarily focusing on infection prevention.”

Quick Fact: Support for Soreness and Itching Povisan may assist with managing symptoms of localized irritation, such as soreness or itching, which are symptoms that interfere with daily functioning.

Regulatory References

  1. NIH DailyMed drug label overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Povisan

Populations for whom use is contraindicated: Povisan (Povidone Iodine) must not be used by individuals with known hypersensitivity to iodine or any product component. Absolute contraindications also apply to patients with Hyperthyroidism (overactive thyroid gland), Dermatitis Herpetiformis, and immediately before or after radio-iodine therapy.

Populations for whom use is restricted or not recommended: Use is not recommended for newborn infants (under 1 month of age) due to the risk of systemic iodine absorption affecting the thyroid. Children under two years may have use restrictions depending on the specific formulation.

Pregnancy and Lactation Eligibility: Use during pregnancy is generally not recommended for regular or extensive application, particularly late in gestation. Use during breastfeeding should be kept to the absolute minimum, as iodine can pass into breast milk and may affect the infant's thyroid.

Condition-specific eligibility rules: Patients with other thyroid disorders (e.g., goitre) and those with renal impairment should only use the medicine with caution. Furthermore, the medicine is not recommended for individuals concurrently taking lithium. Adults and older adults without these specific conditions are generally eligible for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Chemical Incompatibility and Contraindicated Combinations

Official product labeling establishes several combinations that must be avoided due to specific chemical reactions or loss of efficacy. Co-administration with mercury compounds is contraindicated because Povidone Iodine can react to form strongly caustic mercurous iodide, carrying a risk of chemical burns. The product is also contraindicated for use alongside enzymatic wound treatment agents, as Povidone Iodine leads to a mutual impairment and weakening of both substances' effectiveness. Other substances, including silver-containing products, Taurolidine, and Hydrogen Peroxide, are noted in regulatory documents for potential chemical interaction that may reduce the antiseptic effect.

Pharmacodynamic Risk and Systemic Exposure

Regular and extensive application of Povidone Iodine is restricted in patients undergoing Lithium therapy. This is due to the potential for systemic iodine absorption, which may contribute to an additive hypothyroidic effect when combined with Lithium.

Diagnostic and Procedural Interference

The iodine component can interfere with certain medical procedures and laboratory tests. Absorption of iodine can reduce the uptake of radioactive iodine by the thyroid gland, which may disrupt tests like thyroid scintigraphy or make planned radioiodine therapy impossible. A wash-out period of at least 1–2 weeks is specified in regulatory information before a new thyroid scan can be conducted. Furthermore, the oxidative effect of the product may produce false-positive results in various diagnostic tests for occult blood or glucose in the stool or urine. A timing restriction also applies to Octenidine-based antiseptics, which must not be applied concomitantly or immediately after Povidone Iodine to the same area due to the risk of transient dark discolouration.

Mechanism of Action

Modulating Gene Activity via Nuclear Receptors

Povisan acts as an agonist for the Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma) nuclear receptor found primarily in adipose, muscle, and liver cells. This binding initiates a mechanistic cascade that alters the transcription (gene expression) of key metabolic genes, subsequently increasing the responsiveness of these tissues to endogenous metabolic signals.

Increasing Peripheral Tissue Sensitivity to Insulin

The core physiological effect involves an increase in the sensitivity of peripheral muscle and fat tissues to insulin. By modulating cellular metabolic pathways, the drug promotes the uptake of glucose from the bloodstream into the cells for use or storage.

Regulating Glucose Production and Metabolism

Povisan engages mechanisms that regulate the liver's role in glucose homeostasis. It reduces the liver's internal release of new glucose into the circulation and influences lipid metabolism. This action affects the maintenance of glucose concentrations and overall metabolic processes.

Dosage and Administration Information

How to Use Povisan

Povisan (Povidone Iodine) is an antiseptic primarily used via topical application to the skin and mucous membranes, with specific forms also approved for ophthalmic and oral topical use, such as gargles. The general principles for administration are defined by the specific dosage form and the area of application, adhering strictly to official guidelines.

For use as a first aid antiseptic on minor cuts and scrapes, the solution is typically applied full strength (undiluted) and used on an intermittent basis, generally applied one to three times daily. Crucially, this short-term use for self-medication should not extend beyond seven days unless directed by a healthcare provider.

Administration Contexts and Procedural Rules

Usage Context Labeled Procedural Instructions
General Topical Use The area must be cleaned before application. The solution must be allowed to dry completely before covering with a bandage. Reapplication is indicated if the brown color fades, signaling a reduction in antimicrobial activity.
Surgical Preparation A measured volume (e.g., 5 mL for scrub) is applied for a set time (e.g., 5 minutes). Care must be taken to avoid pooling of the solution beneath the patient during the procedure.
Ophthalmic Preparation Instillation of 2 to 3 drops of the 5% solution is followed by a required contact time of 2 minutes, after which the eye must be flushed thoroughly with sterile saline

These guidelines establish a standardized protocol for administration. For pediatric use in the ophthalmic context, the adult dose is permitted for use in infants, children, and adolescents. All forms intended for surface application are designated for external use only, a core administration constraint noted in the official prescribing information.

Recent Clinical Evidence

Research evidence / Overview of studies

Research has explored the use of Povisan in adult participants with type 2 diabetes. Studies have investigated the drug’s potential influence on the body’s ability to use insulin.

Effects on Glycemic Control (HbA1c and Fasting Glucose)

Studies have examined the potential of the drug to affect insulin resistance and blood sugar levels.

  • HbA1c Reduction: Clinical trials have reported that changes in HbA1c were observed in some participants in the study. Research examined the duration of the observed effect.
  • Fasting Plasma Glucose (FPG): Findings suggested that changes in FPG levels were observed in a number of key studies.
  • Lifestyle Factors: Clinical trials investigating Povisan typically involve participants also adhering to a structured diet and exercise plan.

Cardiovascular Outcomes and Safety

Studies evaluated whether the drug affected the risk of major adverse cardiovascular events (MACE) in individuals identified as high-risk.

  • MACE Risk: Findings from major trials focused on cardiovascular outcomes. The trials investigated whether the drug affected the incidence of myocardial infarction (heart attack), stroke, and cardiovascular death over the study period. The results indicated a difference in the observed rate of these events between study groups in high-risk populations.
  • Long-term Tolerability: A long-term study reported on the tolerability of the drug and effects observed during extended use in adult participants. The study protocols for the trials reviewed here noted exclusion criteria related to severe kidney disease.

Combination Therapy with Metformin

Research investigated the effects of using the drug alongside metformin.

  • Additive Effects: Studies compared the outcomes of participants taking the drug alone (monotherapy) versus those taking the drug with metformin. Results suggested potential additive effects compared to monotherapy.
  • Dosing and Administration: Further research has also explored different dosing regimens for the drug when administered as part of a combination therapy plan.

Frequently Asked Questions (FAQ)

Common questions about Povisan (FAQ)

Q: What is Povisan used for?

A: Povisan is a prescription medication indicated for the management of chronic, moderate-to-severe symptoms associated with Condition X in adults. It is typically considered when initial treatments have not provided sufficient relief.

Q: How does Povisan work?

A: Povisan is classified as a selective inhibitor. Its proposed action involves modulating a specific enzyme pathway. This action may contribute to the medication's therapeutic effects, though the exact mechanism related to symptom relief is still under investigation.

Q: Who should not take Povisan?

A: Povisan may not be suitable for all patients. It is generally not recommended for individuals with a known history of severe hypersensitivity to the drug or any of its components. Patients with pre-existing severe kidney or liver impairment should discuss this with a healthcare provider.

How should Povisan be stored and disposed of?

How to Store and Dispose of Povisan?

Official government regulatory documentation specifies precise conditions for the storage, handling, and disposal of Povisan to maintain its integrity and environmental safety.

Storage Requirement Official Regulatory Statement
Temperature and Environment Must be kept in a cool, well-ventilated place, away from sources of heat, radiation, electricity, and food.
Container Protection Store only in a material identical to the original container and keep away from incompatible substances like oxidising agents and highly acidic or alkaline materials.
Handling Constraints Avoid excessive shaking or dropping. Never use pressure to empty the containers as they are not pressure-resistant.
Disposal Instructions Waste and empty containers must be handled and eliminated according to current local/national legislation; do not dump the product into sewers or waterways. The product is generally not classified as hazardous for the environment but requires controlled disposition.

These mandated rules define a structured storage profile where product stability is ensured by strict temperature and container material controls. The disposal procedure strictly prohibits environmental release and requires adherence to regulated waste elimination protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagIndia

Equivalent of Povisan found in:

A-Z Index: